General information

Announcements(0)

Overview

Manual for Online Meeting

Participant Registration

Abstract Submission (Oral/Poster Presentation)

General information 2

Abstract Submission (Late-Breaking Session)

Program

Sessions

Search presentations

pharm141_en.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

A password that applicants have been notified of is required to view abstracts.<br>If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.<br>We will reply after confirming that you were a participant.<br>Thank you for your understanding.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Profile management

Announcements

Bookmark

Download PDF for print

Timetable

Improvement effect of sak3, t-type calcium channel activator, on a mouse model of dementia with lewy bodies.

The ratio of the elderly population aged 65 and over to the total population in Japan (2020) is the highest (28.9%) in the world, and it is expected to continue to rise in the future. In a super-aging society, the number of patients with cancer, cardiovascular disease, dementia and depressive illness is increasing, and it is necessary to clarify the causes of onset and/or progression and problems with drug treatment. <br />Therefore, this symposium will consist of research presentations from next-generation young researchers working on a basic research focused on elucidation of pathological conditions of dementia, depressive illness and pain and establishment of new drug treatments for such illnesses, and clinical research verifying new effects of existing drugs (prevention and treatment of side effects induced by various anticancer drugs) from the view of drug repositioning. We really hope that this symposium will provide a great opportunity to exchange opinions and to share the latest information on various problems in clinical practice and their solutions for students and young researchers who will be responsible for future medical care.

The development of pharmaceutical research and contribution to medical care opened up by the next-generation young researchers

The 141st Annual Meeting of the Pharmaceutical Society of Japan (Hiroshima)

Presentation Information

[GS04-4]Improvement effect of sak3, t-type calcium channel activator, on a mouse model of dementia with lewy bodies.

Password required to view